Zacks Investment Research upgraded shares of Catasys (NASDAQ:CATS) from a sell rating to a hold rating in a report released on Tuesday morning.
According to Zacks, “Catasys, Inc., formerly known as Hythiam, Inc., provides specialized behavioral health management services to health plans, employers and unions through a network of licensed and company managed health care providers. The Company’s program seeks to improve member health by delivering medical and psychosocial interventions in combination with long term care coaching, including their proprietary treatment program for alcoholism and stimulant dependence. Catasys, Inc. is based in Los Angeles. “
CATS has been the topic of a number of other reports. ValuEngine upgraded shares of Catasys from a hold rating to a buy rating in a report on Friday, June 1st. Canaccord Genuity began coverage on shares of Catasys in a report on Monday. They issued a buy rating and a $10.00 price target on the stock. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of Buy and a consensus price target of $9.00.
Catasys (NASDAQ:CATS) last posted its quarterly earnings data on Tuesday, May 15th. The company reported ($0.27) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.26) by ($0.01). The firm had revenue of $1.91 million for the quarter, compared to the consensus estimate of $3.00 million. Catasys had a net margin of 50.55% and a negative return on equity of 546.50%. analysts forecast that Catasys will post -0.73 earnings per share for the current year.
In related news, Director Steve Gorlin purchased 20,235 shares of the business’s stock in a transaction dated Friday, June 15th. The shares were purchased at an average cost of $8.40 per share, for a total transaction of $169,974.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 92.20% of the company’s stock.
An institutional investor recently bought a new position in Catasys stock. Weber Alan W bought a new position in shares of Catasys, Inc. (NASDAQ:CATS) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 108,165 shares of the company’s stock, valued at approximately $406,000. Weber Alan W owned approximately 0.68% of Catasys at the end of the most recent reporting period. Hedge funds and other institutional investors own 4.75% of the company’s stock.
Catasys Company Profile
Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.